Trivalent Oral Poliomyelitis vaccine (GlaxoSmithKline)

N/A

Report date: 2024/12/11 10:09:24

Base Information

Drug NameTrivalent Oral Poliomyelitis vaccine (GlaxoSmithKline)

Drug Alias NamePolio Sabin

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsPoliomyelitis

Inactive IndicationsN/A

ATC CodeJ07BF03